Language

News topic

Active ingredient Hepatitis B virus surface antigen (recombinant)

Current shortage notices for the active ingredient Hepatitis B virus surface antigen (recombinant), structured by product, country and reporting period.

4 notices

← All shortages

What the Hepatitis B virus surface antigen (recombinant) notices indicate for the supply chain

The 4 consolidated notices from Belgium are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Belgium

Engerix B 20 µg/1 ml inj. susp. s.c./i.m. pre-filled syr. 1 dose (1 ml)

Active ingredient: Hepatitis B virus surface antigen (recombinant)

View notice details →
Belgium

Engerix B 20 µg/1 ml inj. susp. s.c./i.m. pre-filled syr. 1 dose (1 ml)

Active ingredient: Hepatitis B virus surface antigen (recombinant)

View notice details →
Belgium

Engerix B 20 µg/1 ml inj. susp. s.c./i.m. voorgev. spuit 1 dosis (1 ml)

Active ingredient: Hepatitis B virus surface antigen (recombinant)

View notice details →
Belgium

Twinrix Adult inj. susp. i.m./s.c. voorgev. spuit 1 dosis (1 ml)

Active ingredient: Hepatitis A Virus Antigene (Hav Antigen) Vaccin; Hepatitis B virus surface antigen (recombinant)

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.